To see more information:

Konstantin Mazalov

Corporate business media and news feed

The Company Story

We are a science-based and collaborative CDMO that supports pharmaceutical development from early development to commercialization. The focus of our work is to help customers move from complex scientific and manufacturing challenges to a clear and reliable path. During the development of medicines, several simultaneous issues often need to be solved: how to develop the active substance and pharmaceutical form, how to ensure the necessary analytical support, and how to lead processes to firmly scalable production. This is particularly important when it comes to complex molecules, controlled

Dropdown

all articles

Scalifying the development and production of the active substance on a reliable route to the market

The development of the active substance   is a critical step in the life cycle of any pharmaceutical, chemical or biotechnology project. If the aim is to lead t
ssb.ee
The development of the active substance is a critical step in the life cycle of any pharmaceutical, chemical or biotechnology project. If the aim is to lead the idea from laboratory to stable and controlled large-scale production, a partner is needed that can support the whole process - from the initial development stages to the production and scaling of the end materials. < Professional development of the active substance helps to ensure that each next stage is based on a solid technical basis. This means better process control, greater recovery, a clearer quality framework and a

Are you sure you want to delete this article?

Loader

Loader

App Ad

Scorestorybook Chrome extension

The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.